Overexpression of facioscapulohumeral muscular dystrophy region gene 1 causes primary defects in myogenic stem cells

Journal of Cell Science

Volumn 126, Issue 10, 2013, Pages 2236-2245

  Xynos, Alexandros ^a   Neguembor, Maria Victoria ^a,b   Caccia, Roberta ^a   Licastro, Danilo ^c   Nonis, Alessandro ^b   Serio, Clelia Di ^b   Stupka, Elia ^c,d   Gabellini, Davide ^a  

^a DULBECCO TELETHON INSTITUTE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c CBM Scrl Basovizza   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Epigenetics; Muscle stem cells; Muscular dystrophy

Indexed keywords

ARTICLE; CLONOGENESIS; DOWN REGULATION; EPIGENETICS; EX VIVO STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY REGION GENE 1; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOFLUORESCENCE; MUSCLE REGENERATION; NONHUMAN; PHENOTYPE; POSTNATAL GROWTH; PRIORITY JOURNAL; STEM CELL; WILD TYPE;

EPIGENETICS; MUSCLE STEM CELLS; MUSCULAR DYSTROPHY;

ACTIN CYTOSKELETON; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CELL LINE; CELL SURFACE EXTENSIONS; CYTOSKELETAL PROTEINS; MACROPHAGES; MICE; MULTIPOTENT STEM CELLS; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; TRANSGENES; WISKOTT-ALDRICH SYNDROME PROTEIN;

ANURA; MUS;

EID: 84879856340     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.121533     Document Type: Article

References (59)

1. Anderson, J. E. (2000). A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol. Biol. Cell 11, 1859-1874.
2. Arashiro, P., Eisenberg, I., Kho, A. T., Cerqueira, A. M., Canovas, M., Silva, H. C., Pavanello, R. C., Verjovski-Almeida, S., Kunkel, L. M. and Zatz, M. (2009). Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers. Proc. Natl. Acad. Sci. USA 106, 6220-6225.
3. Bakay, M., Wang, Z., Melcon, G., Schiltz, L., Xuan, J., Zhao, P., Sartorelli, V., Seo, J., Pegoraro, E., Angelini, C. et al. (2006). Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 129, 996-1013.
4. Bentzinger, C. F., Wang, Y. X. and Rudnicki, M. A. (2012). Building muscle: molecular regulation of myogenesis. Cold Spring Harb. Perspect. Biol. 4, a008342.
5. Bortolanza, S., Nonis, A., Sanvito, F., Maciotta, S., Sitia, G., Wei, J., Torrente, Y., Di Serio, C., Chamberlain, J. R. and Gabellini, D. (2011). AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy. Mol. Ther. 19, 2055-2064.
6. Cabianca, D. S. and Gabellini, D. (2010). The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy. J. Cell Biol. 191, 1049-1060.
7. Cabianca, D. S., Casa, V., Bodega, B., Xynos, A., Ginelli, E., Tanaka, Y. and Gabellini, D. (2012). A long ncRNA links copy number variation to a polycomb/ trithorax epigenetic switch in FSHD muscular dystrophy. Cell 149, 819-831.
8. Carlson, M. E. and Conboy, I. M. (2007). Loss of stem cell regenerative capacity within aged niches. Aging Cell 6, 371-382.
9. Carlson, M. E., Hsu, M. and Conboy, I. M. (2008). Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528-532.
10. Chargé, S. B. and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
11. Chen, S. C., Frett, E., Marx, J., Bosnakovski, D., Reed, X., Kyba, M. and Kennedy, B. K. (2011). Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1. PLoS ONE 6, e19780.
12. Clark, L. N., Koehler, U., Ward, D. C., Wienberg, J. and Hewitt, J. E. (1996). Analysis of the organisation and localisation of the FSHD-associated tandem array in primates: implications for the origin and evolution of the 3.3 kb repeat family. Chromosoma 105, 180-189.
13. Conboy, I. M., Conboy, M. J., Smythe, G. M. and Rando, T. A. (2003). Notchmediated restoration of regenerative potential to aged muscle. Science 302, 1575-1577.
14. Dalkilic, I. and Kunkel, L. M. (2003). Muscular dystrophies: genes to pathogenesis. Curr. Opin. Genet. Dev. 13, 231-238.
15. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O. et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367.
16. Du, P., Kibbe, W. A. and Lin, S. M. (2008). lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548.
17. Dubowitz, V. (1985). Muscle Biopsy: a Practical Approach. London: Bailliere Tindall. Durbeej, M. and Campbell, K. P. (2002). Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12, 349-361.
18. Durbeej, M. and Campbell, K. P. (2002). Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12, 349-361.
19. Fitzsimons, R. B., Gurwin, E. B. and Bird, A. C. (1987). Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 110, 631-648.
20. Fukada, S., Higuchi, S., Segawa, M., Koda, K., Yamamoto, Y., Tsujikawa, K., Kohama, Y., Uezumi, A., Imamura, M., Miyagoe-Suzuki, Y. et al. (2004). Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp. Cell Res. 296, 245-255.
21. Gabellini, D., Green, M. R. and Tupler, R. (2002). Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110, 339-348.
22. Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., Angeletti, B., Ciscato, P., Pellegrino, M. A., Bottinelli, R. et al. (2006). Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439, 973-977.
23. Gnocchi, V. F., White, R. B., Ono, Y., Ellis, J. A. and Zammit, P. S. (2009). Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells. PLoS ONE 4, e5205.
24. Hanel, M. L., Wuebbles, R. D. and Jones, P. L. (2009). Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev. Dyn. 238, 1502-1512.
25. Hanel, M. L., Sun, C. Y., Jones, T. I., Long, S. W., Zanotti, S., Milner, D. and Jones, P. L. (2011). Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein. Differentiation 81, 107-118.
26. Jones, T. I., Chen, J. C., Rahimov, F., Homma, S., Arashiro, P., Beermann, M. L., King, O. D., Miller, J. B., Kunkel, L. M., Emerson, C. P., Jr et al. (2012). Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum. Mol. Genet. 21, 4419-4430.
27. Kilmer, D. D., Abresch, R. T., McCrory, M. A., Carter, G. T., Fowler, W. M., Jr, Johnson, E. R. and McDonald, C. M. (1995). Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am. J. Phys. Med. Rehabil. 74 Suppl. 1, S131-S139.
28. Klooster, R., Straasheijm, K., Shah, B., Sowden, J., Frants, R., Thornton, C., Tawil, R. and van der Maarel, S. (2009). Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur. J. Hum. Genet. 17, 1615-1624.
29. Krom, Y. D., Thijssen, P. E., Young, J. M., den Hamer, B., Balog, J., Yao, Z., Maves, L., Snider, L., Knopp, P., Zammit, P. S. et al. (2013). Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet. 9, e1003415.
30. Kudryashova, E., Kramerova, I. and Spencer, M. J. (2012). Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H. J. Clin. Invest. 122, 1764-1776.
31. Lemmers, R. J., van der Vliet, P. J., Klooster, R., Sacconi, S., Caman o, P., Dauwerse, J. G., Snider, L., Straasheijm, K. R., van Ommen, G. J., Padberg, G. W. et al. (2010). A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653.
32. Liu, Q., Jones, T. I., Tang, V. W., Brieher, W. M. and Jones, P. L. (2010). Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. J. Cell Sci. 123, 1116-1123.
33. Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. and Woolf, P. J. (2009). GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 161.
34. Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L. and Munoz-Cánoves, P. (2011). Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1, 21.
35. Masny, P. S., Chan, O. Y., de Greef, J. C., Bengtsson, U., Ehrlich, M., Tawil, R., Lock, L. F., Hewitt, J. E., Stocksdale, J., Martin, J. H. et al. (2010). Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei. Eur. J. Hum. Genet. 18, 448-456.
36. Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A. and Kardon, G. (2011). Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138, 3625-3637.
37. Orrell, R. W., Tawil, R., Forrester, J., Kissel, J. T., Mendell, J. R. and Figlewicz, D. A. (1999). Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology 52, 1822-1826.
38. Osborne, R. J., Welle, S., Venance, S. L., Thornton, C. A. and Tawil, R. (2007). Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68, 569-577.
39. Padberg, G. W., Brouwer, O. F., de Keizer, R. J., Dijkman, G., Wijmenga, C., Grote, J. J. and Frants, R. R. (1995). On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 2, S73-S80.
40. Rahimov, F., King, O. D., Leung, D. G., Bibat, G. M., Emerson, C. P., Jr, Kunkel, L. M. and Wagner, K. R. (2012). Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc. Natl. Acad. Sci. USA 109, 16234-16239.
41. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P. and Rudnicki, M. A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786.
42. Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., Kawasaki, E. S., Lee, K. Y. et al.; MAQC Consortium (2006). The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24, 1151-1161.
43. Smythe, G. (2005). Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York, NY: Springer.
44. Snider, L., Asawachaicharn, A., Tyler, A. E., Geng, L. N., Petek, L. M., Maves, L., Miller, D. G., Lemmers, R. J., Winokur, S. T., Tawil, R. et al. (2009). RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet. 18, 2414-2430.
45. Snider, L., Geng, L. N., Lemmers, R. J., Kyba, M., Ware, C. B., Nelson, A. M., Tawil, R., Filippova, G. N., van der Maarel, S. M., Tapscott, S. J. et al. (2010). Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181.
46. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S. et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550.
47. Sun, C. Y., van Koningsbruggen, S., Long, S. W., Straasheijm, K., Klooster, R., Jones, T. I., Bellini, M., Levesque, L., Brieher, W. M., van der Maarel, S. M. et al. (2011). Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNAassociated and actin-bundling protein. J. Mol. Biol. 411, 397-416.
48. Tatsumi, R., Hattori, A., Ikeuchi, Y., Anderson, J. E. and Allen, R. E. (2002). Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol. Biol. Cell 13, 2909-2918.
49. Tatsumi, R., Liu, X., Pulido, A., Morales, M., Sakata, T., Dial, S., Hattori, A., Ikeuchi, Y. and Allen, R. E. (2006). Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. Am. J. Physiol. Cell Physiol. 290, C1487-C1494.
50. Tsumagari, K., Chang, S. C., Lacey, M., Baribault, C., Chittur, S. V., Sowden, J., Tawil, R., Crawford, G. E. and Ehrlich, M. (2011). Gene expression during normal and FSHD myogenesis. BMC Med. Genomics 4, 67.
51. van der Maarel, S. M., Tawil, R. and Tapscott, S. J. (2011). Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol. Med. 17, 252-258.
52. van Deutekom, J. C., Wijmenga, C., van Tienhoven, E. A., Gruter, A. M., Hewitt, J. E., Padberg, G. W., van Ommen, G. J., Hofker, M. H. and Frants, R. R. (1993). FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037-2042.
53. van Koningsbruggen, S., Dirks, R. W., Mommaas, A. M., Onderwater, J. J., Deidda, G., Padberg, G. W., Frants, R. R. and van der Maarel, S. M. (2004). FRG1P is localised in the nucleolus, Cajal bodies, and speckles. J. Med. Genet. 41, e46.
54. van Koningsbruggen, S., Straasheijm, K. R., Sterrenburg, E., de Graaf, N., Dauwerse, H. G., Frants, R. R. and van der Maarel, S. M. (2007). FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma 116, 53-64.
55. Volonte, D., Liu, Y. and Galbiati, F. (2005). The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J. 19, 237-239.
56. White, R. B., Biérinx, A. S., Gnocchi, V. F. and Zammit, P. S. (2010). Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev. Biol. 10, 21.
57. Wijmenga, C., Hewitt, J. E., Sandkuijl, L. A., Clark, L. N., Wright, T. J., Dauwerse, H. G., Gruter, A. M., Hofker, M. H., Moerer, P., Williamson, R. et al. (1992). Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 2, 26-30.
58. Wuebbles, R. D., Hanel, M. L. and Jones, P. L. (2009). FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis. Model. Mech. 2, 267-274.
59. Xynos, A., Corbella, P., Belmonte, N., Zini, R., Manfredini, R. and Ferrari, G. (2010). Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway. Stem Cells 28, 965-973.